Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,580.20
3.9 (0.25%)
BSENSE

Jul 31, 03:30 PM

BSE+NSE Vol: 4.55 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 164981,
    "name": "Aurobindo Pharma",
    "stock_name": "Aurobindo Pharma",
    "full_name": "Aurobindo Pharma Ltd.",
    "name_url": "stocks-analysis/aurobindo-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,580.20",
    "chg": 3.9,
    "chgp": "0.25%",
    "dir": 1,
    "prev_price": "1,576.30",
    "mcapval": "91,659.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524804,
    "symbol": "AUROPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE406A01037",
    "curr_date": "Jul 31, 03:30 PM",
    "curr_time": "17:44 PM",
    "last_traded_at": "Jul 31, 03:30 PM IST",
    "bse_nse_vol": "4.55 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-4127759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_technicaldot_4127759.png",
        "date": "2026-07-30 08:00:17",
        "description": "Aurobindo Pharma Ltd. has demonstrated a notable shift in technical momentum, moving from a mildly bullish stance to a more confident bullish trend across multiple timeframes. This transition is underscored by positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, suggesting renewed investor interest and potential upside in the pharmaceutical sector amid broader market fluctuations."
      },
      {
        "title": "When is the next results date for Aurobindo Pharma Ltd.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aurobindo-pharma-ltd-4124743",
        "imagepath": "",
        "date": "2026-07-28 23:17:11",
        "description": "Aurobindo Pharma Ltd. will declare its results on 05 August 2026...."
      },
      {
        "title": "Aurobindo Pharma’s Mixed Week: -0.17% Price Change Amid Surging Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharmas-mixed-week--017-price-change-amid-surging-derivatives-activity-4121493",
        "imagepath": "",
        "date": "2026-07-26 16:03:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> Stock opens strong at Rs.1,560.55 (+1.73%) amid stable market conditions</p>\n                    <p><strong>22 Jul:</strong> Sharp open interest surge in derivatives despite 3.01% price decline</p>\n                    <p><strong>24 Jul:</strong> Technical momentum shifts to mildly bullish with mixed indicator signals</p>\n                    <p><strong>24 Jul:</strong> Week closes at Rs.1,531.50 (-0.17%) outperforming Sensex decline</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,534.05<..."
      },
      {
        "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4118457",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_technicaldot_4118457.png",
        "date": "2026-07-24 08:00:29",
        "description": "Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a modest day decline of 0.59%, the stock’s technical indicators present a complex picture, with some signals suggesting sustained strength while others hint at caution. This nuanced technical landscape warrants close attention from investors seeking to navigate the stock’s evolving trend dynamics."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-4116491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_oi_spurts_by_underlying_4116491.png",
        "date": "2026-07-22 15:00:09",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable 13.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay of volume patterns and price movements that investors must carefully analyse."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-price-action-4116418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_oi_spurts_by_underlying_4116418.png",
        "date": "2026-07-22 14:00:09",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable 13.4% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and price movements, suggests evolving market positioning and potential directional bets among traders."
      },
      {
        "title": "Aurobindo Pharma Sees Significant Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-significant-open-interest-surge-amid-mixed-price-action-4116408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_oi_spurts_by_underlying_4116408.png",
        "date": "2026-07-22 13:00:08",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable 10.9% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a 2.94% decline in the stock price on 22 Jul 2026, the surge in open interest and volume patterns suggest evolving directional bets amid broader sector and market pressures."
      },
      {
        "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-price-action-4115326",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_oi_spurts_by_underlying_4115326.png",
        "date": "2026-07-22 12:00:08",
        "description": "Aurobindo Pharma Ltd. has witnessed a notable 10.46% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and price movements, offers insights into evolving market positioning and potential directional bets by investors in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Aurobindo Pharma Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-4115057",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AurobindoPharma_mojoScore_4115057.png",
        "date": "2026-07-22 10:11:01",
        "description": "Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 846,
    "sid": "164981",
    "stock_news_url": "https://www.marketsmojo.com/news/aurobindo-pharma-164981"
  },
  "announcements": [
    {
      "details": "Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of USFDA Inspection at our Unit IV Reg.,'.",
      "source": "NSE",
      "caption": "Aurobindo Pharma Limited - Updates",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "05 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11",
          "dt": "2011-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15",
          "dt": "2015-07-20",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Aurobindo Pharma’s Mixed Week: -0.17% Price Change Amid Surging Derivatives Activity

2026-07-26 16:03:03

Key Events This Week

20 Jul: Stock opens strong at Rs.1,560.55 (+1.73%) amid stable market conditions

22 Jul: Sharp open interest surge in derivatives despite 3.01% price decline

24 Jul: Technical momentum shifts to mildly bullish with mixed indicator signals

24 Jul: Week closes at Rs.1,531.50 (-0.17%) outperforming Sensex decline

stock-recommendationAnnouncement

Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates

28-Nov-2019 | Source : NSE

Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates

15-Nov-2019 | Source : NSE

Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Aurobindo Pharma Limited - Updates

14-Nov-2019 | Source : NSE

Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of USFDA Inspection at our Unit IV Reg.,'.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

05 Aug 2026

stock-summary
DIVIDEND

Aurobindo Pharma Ltd. has declared 400% dividend, ex-date: 08 Aug 25

stock-summary
SPLITS

Aurobindo Pharma Ltd. has announced 1:5 stock split, ex-date: 10 Feb 11

stock-summary
BONUS

Aurobindo Pharma Ltd. has announced 1:1 bonus issue, ex-date: 20 Jul 15

stock-summary
RIGHTS

No Rights history available